An In Silico Study for Expanding the Utility of Cannabidiol in Alzheimer’s Disease Therapeutic Development
出版年份 2023 全文链接
标题
An In Silico Study for Expanding the Utility of Cannabidiol in Alzheimer’s Disease Therapeutic Development
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 24, Issue 21, Pages 16013
出版商
MDPI AG
发表日期
2023-11-07
DOI
10.3390/ijms242116013
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Cannabinoids in neuroinflammatory disorders: Focusing on multiple sclerosis, Parkinsons, and Alzheimers diseases
- (2023) Bahareh Abd‐Nikfarjam et al. BIOFACTORS
- CIRCE: Web-Based Platform for the Prediction of Cannabinoid Receptor Ligands Using Explainable Machine Learning
- (2023) Nicola Gambacorta et al. Journal of Chemical Information and Modeling
- A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD)
- (2022) Jiangling Peng et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Recent Advances on Type-2 Cannabinoid (CB2) Receptor Agonists and Their Therapeutic Potential
- (2022) Valeria Gasperi et al. CURRENT MEDICINAL CHEMISTRY
- New cannabidiol (CBD) derivatives: Synthesis, anti-inflammatory activity, and molecular docking
- (2022) Cheng-Ting Zi et al. Phytochemistry Letters
- Cannabidiol as a Therapeutic Target: Evidence of its Neuroprotective and Neuromodulatory Function in Parkinson’s Disease
- (2021) Felipe Patricio et al. Frontiers in Pharmacology
- De novo design of new chemical entities for SARS-CoV-2 using artificial intelligence
- (2021) Navneet Bung et al. Future Medicinal Chemistry
- Roles of Cannabidiol in the treatment and prevention of Alzheimer’s disease by multi-target actions
- (2021) Xiao- Bei Zhang et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Investigation of the Multi-Target Mechanism of Guanxin-Shutong Capsule in Cerebrovascular Diseases: A Systems Pharmacology and Experimental Assessment
- (2021) Juanli Zhang et al. Frontiers in Pharmacology
- Computational insights into binding mechanism of drugs as potential inhibitors against SARS-CoV-2 targets
- (2021) Mahreen Arooj et al. CHEMICAL PAPERS
- Understanding the Modulatory Effects of Cannabidiol on Alzheimer’s Disease
- (2021) Yinyi Xiong et al. Brain Sciences
- Molecular Simulation Study on the Interaction between Tyrosinase and Flavonoids from Sea Buckthorn
- (2021) Xiaofang Li et al. ACS Omega
- Virtual screening using docking and molecular dynamics of cannabinoid analogs against CB1 and CB2 receptors
- (2021) Antistio Aviz-Amador et al. COMPUTATIONAL BIOLOGY AND CHEMISTRY
- Activation of GPR55 attenuates cognitive impairment and neurotoxicity in a mouse model of Alzheimer's disease induced by Aβ1–42 through inhibiting RhoA/ROCK2 pathway
- (2021) XiaoTong Xiang et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- From Cannabis sativa to Cannabidiol: Promising Therapeutic Candidate for the Treatment of Neurodegenerative Diseases
- (2020) Tommaso Cassano et al. Frontiers in Pharmacology
- Overview of cannabidiol (CBD) and its analogues: Structures, biological activities, and neuroprotective mechanisms in epilepsy and Alzheimer’s disease
- (2020) Han Li et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Hyperphosphorylated tau aggregation and cytotoxicity modulators screen identified prescription drugs linked to Alzheimer's disease and cognitive functions
- (2020) Mengyu Liu et al. Scientific Reports
- Emerging potential of cannabidiol in reversing proteinopathies
- (2020) Raju Dash et al. AGEING RESEARCH REVIEWS
- DeepPurpose: a deep learning library for drug–target interaction prediction
- (2020) Kexin Huang et al. BIOINFORMATICS
- Cannabidiol: A Potential New Alternative for the Treatment of Anxiety, Depression, and Psychotic Disorders
- (2020) María S. García-Gutiérrez et al. Biomolecules
- Fragment-Based Discovery of an Apolipoprotein E4 (apoE4) Stabilizer
- (2019) Andrew M. Petros et al. JOURNAL OF MEDICINAL CHEMISTRY
- PrankWeb: a web server for ligand binding site prediction and visualization
- (2019) Lukas Jendele et al. NUCLEIC ACIDS RESEARCH
- GPR3, GPR6, and GPR12 as novel molecular targets: their biological functions and interaction with cannabidiol
- (2018) Alyssa S. Laun et al. ACTA PHARMACOLOGICA SINICA
- Anti-Amyloid-β Monoclonal Antibodies for Alzheimer’s Disease: Pitfalls and Promise
- (2018) Christopher H. van Dyck BIOLOGICAL PSYCHIATRY
- Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors
- (2018) Mylyne Tham et al. BRITISH JOURNAL OF PHARMACOLOGY
- Population-based De Novo Molecule Generation, Using Grammatical Evolution
- (2018) Naruki Yoshikawa et al. CHEMISTRY LETTERS
- In Silico Identification of Novel Apolipoprotein E4 Inhibitor for Alzheimer’s Disease Therapy
- (2018) Saddia Bano et al. Current Computer-Aided Drug Design
- UniProt: a worldwide hub of protein knowledge
- (2018) NUCLEIC ACIDS RESEARCH
- OUP accepted manuscript
- (2017) NUCLEIC ACIDS RESEARCH
- DrugBank 5.0: a major update to the DrugBank database for 2018
- (2017) David S Wishart et al. NUCLEIC ACIDS RESEARCH
- Analysis of natural product regulation of cannabinoid receptors in the treatment of human disease
- (2017) S. Badal et al. PHARMACOLOGY & THERAPEUTICS
- Protein-Ligand Blind Docking Using QuickVina-W With Inter-Process Spatio-Temporal Integration
- (2017) Nafisa M. Hassan et al. Scientific Reports
- In vivo Evidence for Therapeutic Properties of Cannabidiol (CBD) for Alzheimer's Disease
- (2017) Georgia Watt et al. Frontiers in Pharmacology
- SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules
- (2017) Antoine Daina et al. Scientific Reports
- Cannabidiol (CBD) and its analogs: a review of their effects on inflammation
- (2015) Sumner Burstein BIOORGANIC & MEDICINAL CHEMISTRY
- Cannabinoids for Medical Use
- (2015) Penny F. Whiting et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Isolation and Pharmacological Evaluation of Minor Cannabinoids from High-Potency Cannabis sativa
- (2015) Mohamed M. Radwan et al. JOURNAL OF NATURAL PRODUCTS
- A unified lead-oriented synthesis of over fifty molecular scaffolds
- (2015) Richard G. Doveston et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Inhibition of myeloperoxidase activity by the alkaloids of Peganum harmala L. (Zygophyllaceae)
- (2014) Sihem Bensalem et al. JOURNAL OF ETHNOPHARMACOLOGY
- OMIM.org: Online Mendelian Inheritance in Man (OMIM®), an online catalog of human genes and genetic disorders
- (2014) Joanna S. Amberger et al. NUCLEIC ACIDS RESEARCH
- Oxidative stress in Alzheimer’s disease
- (2014) Zhichun Chen et al. Neuroscience Bulletin
- Quantifying the chemical beauty of drugs
- (2012) G. Richard Bickerton et al. Nature Chemistry
- Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death
- (2011) Partha Mukhopadhyay et al. FREE RADICAL BIOLOGY AND MEDICINE
- New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays
- (2010) Jonathan B. Baell et al. JOURNAL OF MEDICINAL CHEMISTRY
- Optimized Hydrophobic Interactions and Hydrogen Bonding at the Target-Ligand Interface Leads the Pathways of Drug-Designing
- (2010) Rohan Patil et al. PLoS One
- Engineering a Ubiquitin Ligase Reveals Conformational Flexibility Required for Ubiquitin Transfer
- (2009) Shu-Bing Qian et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Estimation of synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributions
- (2009) Peter Ertl et al. Journal of Cheminformatics
- CHARMM-GUI: A web-based graphical user interface for CHARMM
- (2008) Sunhwan Jo et al. JOURNAL OF COMPUTATIONAL CHEMISTRY
- Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro
- (2007) A Thomas et al. BRITISH JOURNAL OF PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started